a Bayer spokesman confirmed on Thursday morning in Leverkusen discussions regarding a possible bid. Previously, the US group had announced in St. Louis that he had received an unsolicited, non-binding offer of the German pharmaceutical and agricultural chemical company.
Financial terms called the US company, which is currently on the market 42.4 billion dollars (37.8 billion euros) will be evaluated, not. Bayer is a market capitalization of nearly 80 billion euros. The Board of Directors of Monsanto would examine the offer now. is pending the aforementioned review, there will be no further communication from the company. Bayer also chatted with details covered.
Split Stories SINCE LONG PERIOD
About a Bayer bid for Monsanto was recently speculated. So the Bloomberg news agency had reported last Thursday that Bayer explores a quote. The share price of the German company has since appeared to slightly more than three percent. The Monsanto shares deposited in turn by almost eight percent.
In the chemical industry has long been seething the rumor mill on the future of companies that specialize in the business of agriculture. This is due to lower prices of agricultural commodities, the turmoil in the emerging markets and the recession in Brazil for some time under considerable pressure.
ALSO BASF HAS INTEREST reputed
was this reason also the largest chemical company BASF has been mentioned as a possible prospect for Monsanto. Many experts had previously held a full takeover by one of the German companies rather unlikely. For example, an analyst John Klein from the private bank Berenberg had indeed held a collaboration between Monsanto and Bayer or BASF possible. Takeovers or mergers he countered for less likely.
The US company, which is constantly under fire for its genetically modified products, intends to strengthen its seeds business for some time and had to itself again own acquisitions or partnerships in conventional crop protection envisaged. Recently, Monsanto was but failed several times with its acquisition plans in Europe
MONSANTO TO SYNGENTA FAILED -. ENTIRE INDUSTRY IN MOTION
So the group flashed about in the past year from the Swiss group Syngenta , This will now be the Chinese company ChemChina swallow for 43 billion US dollars. Now Monsanto has itself become a takeover candidate, especially as the company’s share price is for some time, among other things because of a recently capped profit forecast under pressure.
In the chemical industry, the fusion carousel rotates not only the business of agricultural commodities. Thus, US companies Dow Chemical and Dupont plan their merger. They would thus once the industry leader BASF dethrone. However, the two US corporations want to split following the proposed merger in three listed companies
BAYER:. MONSANTO WOULD CORE BUSINESS SELLING
Bayer itself has its center of business last mainly due to the pharmaceuticals divisions of the company aligned. So the parked with the daughter Covestro chemical business was transferred partly to the stock exchange. Currently keep Leverkusen still 64 percent -. But Bayer plans to divest as soon as possible complete by Covestro
Again and again was also speculation about whether Bayer of the division Crop Science, in the business of agricultural materials is bundled, wants to separate. But now is the area which with 10.4 billion euros a little over one-fifth contributed 2015 consolidated sales to be strengthened. Bayer itself said on Thursday the fact that with a Monsanto-acquisition core business will be strengthened.
BAYER / MONSANTO WOULD TO A QUARTER OF INDUSTRY SALES
Monsanto began last year $ 15 billion around and came up with a profit of 2.3 billion dollars. According to a report of the “Wall Street Journal” According to, based on a study by Morgan Stanley, the two companies would sell around a quarter of the pesticides sold worldwide. For a merger talks that Monsanto is situated more in the US, Bayer in Europe and Asia. That could bring the company even better chances in the competition watchdogs.